EXPLORE THE SCIENCE
A study examined the effects of ketamine on sleep arousal metrics in individuals with treatment-resistant depression (TRD) vs. healthy volunteers, finding that ketamine increases certain sleep-related brain activities but does not significantly mediate its ant…
Read article
GLP-1 receptor agonists like semaglutide, used for managing Type 2 diabetes, may be linked to adverse mood changes, necessitating further investigation into their psychiatric effects. Highlights: GLP-1 Receptor Agonists: These medications mimic GLP-1 hormone e…
Read article
TLDR: A patient developed a compulsive chewing behavior when taking mixed amphetamine salts (MAS) for ADHD, highlighting the need to monitor for unusual side effects with stimulant use. Highlights: Patient Background: The patient is a 32-year-old woman with a…
Read article
Antidepressant withdrawal symptoms occur in about one-third of patients stopping antidepressants, with severe symptoms in about 3% of cases – according to a new Lancet Psychiatry review. Highlights: Incidence of Symptoms: Approximately 31% of patients experien…
Read article
Lecanemab shows promise in treating Alzheimer’s disease by reducing clinical deterioration and amyloid-beta plaques, but it has significant adverse effects and requires further research for confirmation. Highlights: FDA Approval: The US FDA authorized lecanema…
Read article
A study used a 7-Tesla MRI to discover that major depressive disorder (MDD) is linked to lower intracortical myelination, particularly in brain regions associated with negative emotions. Highlights: Advanced MRI: The study used Ultra-High Field MRI at 7.0 Tesl…
Read article
A study found that adults recovering from their first COVID-19 infection more than 1-year ago have higher levels of fatigue and other chronic neuropsychiatric symptoms, influenced by vaccination status and socioeconomic factors. Highlights: Adults who had thei…
Read article
A new study uses AutoML and blood DNA methylation data to identify novel gene biomarkers for diagnosing schizophrenia (SCZ) with high accuracy. Highlights: Biomarker Discovery: AutoML identified three schizophrenia-specific gene methylation biomarkers: IGF2BP1…
Read article
Repetitive transcranial magnetic stimulation (rTMS) therapy improves key biochemical markers in major depressive disorder (MDD) patients, indicating its effectiveness as an antidepressant treatment. Highlights: Improved Antioxidant Levels: rTMS therapy signifi…
Read article
A study identified a panel of eight plasma biomarkers that can predict Parkinson’s disease up to seven years before motor symptoms appear. Highlights: Biomarker Panel: The study validated a panel of 8 proteins, including Granulin precursor and Complement C3, u…
Read article